Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Wallerfing

28 clinical trials in Wallerfing, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Wallerfing at a glance
28
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

28 trials in Wallerfing

Open in trial search

Dyslipidaemia

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bempedoic Acid
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:2,4 DICHLOROBENZYL ALCOHOL
  • Sponsor:MEDICE Arzneimittel Puetter GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ivermectin
  • Sponsor:Dermapharm AG

Acne

Recruiting
Registered drug
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Clindamycin
  • Sponsor:Dermapharm AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Clotrimazole
  • Sponsor:Dermapharm AG

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Wallerfing

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on atherosclerotic cardiovascular disease and heart conditions, evaluating new treatments for reducing major adverse cardiovascular events and managing heart failure.

  • ASCVD Management
  • Heart Failure Treatment
  • Cardiovascular Risk Reduction

Research includes novel therapies combining established medications with experimental compounds.

02 Metabolic Disorders

Comprehensive trials examining treatments for hypertriglyceridemia and metabolic conditions, including studies on obesity and type 2 diabetes management.

  • Triglyceride Level Control
  • Weight Management
  • Diabetes Treatment

Multiple approaches to metabolic health improvement through innovative therapeutic solutions.

03 Respiratory Medicine

Advanced research into respiratory syncytial virus infections and COPD, including vaccine development and treatment optimization studies.

  • RSV Vaccination
  • COPD Management
  • Bronchitis Treatment

Focus on both preventive measures and therapeutic interventions for respiratory conditions.

04 Dermatological Studies

Clinical investigations of treatments for various skin conditions, including papulopustular rosacea and fungal infections.

  • Skin Infection Treatment
  • Rosacea Management
  • Acne Therapy

Evaluation of topical treatments and their comparative efficacy.

05 Gastrointestinal Research

Studies examining treatments for functional gastrointestinal disorders, with particular focus on irritable bowel syndrome.

  • IBS Management
  • Digestive Health
  • Gut Function

Investigation of both conventional and herbal therapeutic approaches.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.